Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2024.03.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Alberto Zanetto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Blood Platelets, Thrombopoietin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero dell'Istruzione dell'Università e della Ricerca.
Abstract (Originalsprache)
BACKGROUND: Reticulated platelets (RePLT) are emergency circulating platelets released to contrast peripheral platelet destruction. AIM: We conducted a prospective study to [a] characterize RePLT in cirrhosis; [b] evaluate the association between RePLT and hepatic decompensation/death. METHODS: Cirrhosis patients without hepatocellular carcinoma were prospectively recruited and underwent assessment of RePLT and thrombopoietin (TPO). RePLT were evaluated by cytofluorimetry and immuno-fluorescence microscopy. Twenty healthy subjects were included as controls. Patients were followed for 6 months for hepatic decompensation and further decompensation/ACLF. RESULTS: Forty-five patients were included (Child-Pugh [CP] A/B/C 18/11/16). Compared to controls, RePLT in cirrhosis were significantly increased (0.82% vs. 0.05%; p 2% accurately identified high-risk patients (AUROC 0.818; 95%CI: 0.639-0.997; sensitivity 94%, specificity 73%). CONCLUSION: RePLT in cirrhosis are increased and hyper-activated. In decompensated patients, higher RePLT appear to be associated with worse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.
- Thrombotic and Haemorrhagic Disease Unit and Haemophilia Center, Department of Medicine (DIMED), University of Padova, Italy.
- Thrombotic and Haemorrhagic Disease Unit and Haemophilia Center, Department of Medicine (DIMED), University of Padova, Italy; General Internal Medicine Unit, Azienda Ospedale - Università Padova, Padova, Italy.
- Thrombotic and Haemorrhagic Disease Unit and Haemophilia Center, Department of Medicine (DIMED), University of Padova, Italy; General Internal Medicine Unit, Azienda Ospedale - Università Padova, Padova, Italy. Electron…
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero dell'Istruzione dell'Università e della Ricerca
Zitieren
APA
Zanetto, A., Toffanin, S., Campello, E., Radu, C. M., Gavasso, S., Burra, P., Russo, F. P., Senzolo, M., & Simioni, P. (2024). Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.03.007
Vancouver
Zanetto A, Toffanin S, Campello E, Radu CM, Gavasso S, Burra P, et al. Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.03.007
BibTeX
@article{Zanetto2024,
author = {Zanetto, Alberto and Toffanin, Serena and Campello, Elena and Radu, Claudia Maria and Gavasso, Sabrina and Burra, Patrizia and Russo, Francesco Paolo and Senzolo, Marco and Simioni, Paolo},
title = {Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2024.03.007}
}
EUVIMED